ENTITY

Xenon Pharmaceuticals (XENE US)

7
Analysis
Health CareCanada
Xenon Pharmaceuticals Inc. operates as a clinical-stage bio-pharmaceutical company. The Company discovers and develops therapeutics for human diseases including diseases caused by mutations in ion channels, and glybera, a gene therapy product for the treatment of adult patients with orphan lipid disorder lipoprotein lipase deficiency.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x